1. Home
  2. PLRX vs NTIC Comparison

PLRX vs NTIC Comparison

Compare PLRX & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.11

Market Cap

70.6M

Sector

Health Care

ML Signal

HOLD

Logo Northern Technologies International Corporation

NTIC

Northern Technologies International Corporation

N/A

Current Price

$8.12

Market Cap

81.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PLRX
NTIC
Founded
2015
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
70.6M
81.9M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
PLRX
NTIC
Price
$1.11
$8.12
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$2.67
N/A
AVG Volume (30 Days)
620.5K
8.3K
Earning Date
05-06-2026
04-09-2026
Dividend Yield
N/A
0.49%
EPS Growth
29.97
N/A
EPS
N/A
N/A
Revenue
N/A
$84,234,474.00
Revenue This Year
N/A
$12.49
Revenue Next Year
N/A
$7.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.08
$7.14
52 Week High
$1.95
$10.03

Technical Indicators

Market Signals
Indicator
PLRX
NTIC
Relative Strength Index (RSI) 42.84 44.22
Support Level N/A $7.85
Resistance Level $1.37 $8.53
Average True Range (ATR) 0.05 0.30
MACD -0.00 -0.07
Stochastic Oscillator 25.00 6.84

Price Performance

Historical Comparison
PLRX
NTIC

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.

Share on Social Networks: